Evidence map›Paper›PMID 21835798›Full record

ArticleJournal of virology2011

Characterization of structural features and diversity of variable-region determinants of related quaternary epitopes recognized by human and rhesus macaque monoclonal antibodies possessing unusually potent neutralizing activities.

Chavdar Krachmarov, Zhong Lai, William J Honnen, Aidy Salomon, Miroslaw K Gorny, Susan Zolla-Pazner, James Robinson, Abraham Pinter

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Chavdar KrachmarovPublic Health Research Institute, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA.
Zhong Lai
William J Honnen
Aidy Salomon
Miroslaw K Gorny
Susan Zolla-Pazner
James Robinson
Abraham Pinter
New York University · USTulane University · USVeterans Health Administration · US

Funding

Viral Immunology CoreP01AI088610 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PINTER, ABRAHAM · 2010 to 2014
$15.3M
PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO HIV1R01HL059725 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ZOLLA-PAZNER, SUSAN B · 1997 to 2014
$8.8M
ANTIGENIC PROPERTIES OF THE V1/V2 DOMAIN OF HIV-1 GP120R01AI046283 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PINTER, ABRAHAM · 2000 to 2010
$5.1M
Novel epitopes that mediate broad neutralization of clade B and C HIV-1 isolatesU01AI078410 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PINTER, ABRAHAM · 2008 to 2012
$3.3M
The Immunoglobulin Gene Usage for Anti-V3 Monoclonal AntibodiesR21AI077451 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GORNY, MIROSLAW K · 2008 to 2010
$637k
Antigenic properties of the V1/V2 domain of HIV-1 gp120R56AI046283 · NIAID · PUBLIC HEALTH RESEARCH INSTITUTE · PI PINTER, ABRAHAM · 2005 to 2005
$493k
ANTIGENIC PROPERTIES OF THE V1/V2 DOMAIN OF HIV-1 GP120R21AI046283 · NIAID · PUBLIC HEALTH RESEARCH INSTITUTE · PI PINTER, ABRAHAM · 2000 to 2000
$111k
NHLBI NIH HHS HL59725NHLBI NIH HHS R01 HL059725NIAID NIH HHS AI046283NIAID NIH HHS AI078410NIAID NIH HHS AI088610NIAID NIH HHS AI77451NIAID NIH HHS P01 AI088610NIAID NIH HHS R01 AI046283NIAID NIH HHS R21 AI046283NIAID NIH HHS R21 AI077451NIAID NIH HHS R56 AI046283NIAID NIH HHS U01 AI078410
6 · The paper itself

Abstract

A series of potently neutralizing monoclonal antibodies (MAbs) that target quaternary epitopes on the native Env trimer have recently been described. A common feature shared by these antibodies is the critical involvement of sites in both the V2 and V3 variable domains in antibody recognition. In this study the gp120 variable-region determinants were mapped for eight rhesus macaque monoclonal antibodies (RhMAbs) possessing potently neutralizing activity specific for a quaternary target in SF162 Env and compared to those originally identified for human MAb 2909. These studies showed that determinants for the epitopes defined by the RhMAbs differed in both the V2 (positions 160, 167, and 169) and V3 (positions 313 and 315) regions from 2909, and in a number of cases, from each other. Attempts to reconstitute expression of these epitopes on the cell surface by cotransfecting Envs containing either the V2 or the V3 determinant of the epitope were not successful, suggesting that these epitopes were expressed on individual protomers in a trimer-dependent manner. Several of the V2 positions found to be critical for expression of these quaternary epitopes also significantly affected exposure and neutralization sensitivity of targets in the V3 and CD4-binding domains. These results demonstrated a considerable diversity in the fine structure of this class of epitopes and further suggested a potentially important relationship between the expression of such quaternary epitopes and V1/V2-mediated masking of immunodominant epitopes.

Indexed as

Genetic VariationAmino Acid SequenceAnimalsAntibodies, MonoclonalAntibodies, NeutralizingEpitope MappingEpitopesHIV AntibodiesHIV Envelope Protein gp120HumansMacaca mulattaMolecular Sequence DataNeutralization TestsAntibodies, MonoclonalAntibodies, NeutralizingEpitopesHIV AntibodiesHIV Envelope Protein gp120

Identifiers

PMID21835798
PMCPMC3187505
OpenAlexW2106031220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.